Skip to content
BETA
Sign in Start

Menu

Account

Language

Economy

DKSH and Grünenthal Expand Partnership Across Asia-Pacific

Thai Post One source

DKSH Thailand has announced an expanded collaboration with pharmaceutical company Grünenthal to distribute pain management products across eight Asia-Pacific markets.

According to a report by Thai Post, DKSH (Thailand), through its Healthcare business unit, has entered into an expanded partnership with the German pharmaceutical firm Grünenthal. This agreement aims to broaden the distribution of Grünenthal’s specialized pain management medication portfolio across eight markets in the Asia-Pacific region.

For residents and expatriates in Thailand, this development signifies a strengthening of the local healthcare supply chain, potentially improving the availability of specific therapeutic treatments. As DKSH leverages its extensive logistics network to manage the distribution, the move reflects a broader trend of international pharmaceutical companies utilizing established regional distributors to penetrate Asian markets more effectively.

While the announcement confirms the strategic expansion of the partnership, several details remain to be clarified. The specific list of the eight target countries has not been fully detailed in the initial report, and there is no immediate information regarding how this might affect the pricing or specific availability timelines for individual patients within Thailand. Residents seeking information on specific medications should consult their local healthcare providers or pharmacists, as this news pertains to corporate distribution agreements rather than direct medical advice or changes to local health regulations.